Bosutinib for Successful Treatment‐Free Remission in Chronic Myeloid Leukemia
ABSTRACT Introduction and Objective This study explored the status of patients with chronic myeloid leukemia following the safe discontinuation of frontline or second‐line bosutinib treatment. The goal was to assess the long‐term outcomes and factors influencing treatment‐free remission (TFR) follow...
Saved in:
| Main Authors: | , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2025-05-01
|
| Series: | Cancer Medicine |
| Subjects: | |
| Online Access: | https://doi.org/10.1002/cam4.70822 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|